亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

濟南宏方德醫藥科技有限公司(銷售三部)  

沒有填寫主營業務~~

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:王紅
  • 電話:0531-55505896
  • QQ:2659530578
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 61-12-1
61-12-1
單價 10.00 / 千克對比
銷量 暫無
發貨 山東濟南市付款后3天內
庫存 90000千克起訂1千克
品牌 濟南宏方德
型號 61-12-1
規格 千克
過期 長期有效
更新 2014-04-08 09:19
 
詳細信息

原料藥:

Donepezil HCl (CAS:120011-70-3) ***多奈哌齊,

Donepezil(CAS:120014-06-4)多奈哌齊,
Ropivacaine HCL (CAS:132112-35-7) ***羅哌卡因
,
Ropivacaine Mesylate 甲磺酸羅哌卡因,

Cinchocaine(Dibucaine) HCL (CAS:61-12-1) ***辛可(地布)卡因,

Cinchocaine(Dibucaine) (CAS:85-79-0),辛可(地布)卡因,

Prilocaine HCL (CAS:1786-81-8) ***丙胺卡因,

Prilocaine (CAS:721-50-6)丙胺卡因,

Pramoxine HCL (CAS:637-58-1) ***普莫卡因,
Bupivacaine HCL (CAS:14252-80-3) ***布比卡因,

Bupivacaine(CAS:2180-92-9) 布比卡因,
Levobupivacaine HCL (CAS:27262-48-2),***左布比卡因

Levobupivacaine(CAS:27262-47-1) 左布比卡因,
Mepivacaine HCL (CAS:1722-62-9) ***甲哌卡因,

Levodropropizine (CAS:99291-24-4) 左羥丙哌嗪,
Tiotropium Bromide (CAS:139404-48-1) 噻托溴銨
,
Foscarnet Sodium (CAS:63585-09-1) 膦甲酸鈉
,
Loratadine (CAS:79794-75-5) 氯雷他定,

N-L-alanyl-L-glutamine (CAS:39537-23-0) N-L-丙氨酰-L-谷氨酰胺
Tiopronin (CAS:1953-02-2) 硫普羅寧等。

©2025 濟南宏方德醫藥科技有限公司(銷售三部) 版權所有   技術支持:化工網   訪問量:7737  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |